Dr. Shuren’s wife, Allison Shuren, represented medical device manufacturers as a lawyer with the Arnold & Porter law firm in Washington, D.C., during Dr. Shuren’s FDA tenure, according to The New York Times.
Here are six takeaways from the Times’ investigation:
- Dr. Shuren was the FDA’s director of the Center for Devices and Radiological Health for 15 years before retiring this year. He is assisting the agency in the search for his successor.
- Dr. Shuren signed ethics agreements to shield him from FDA matters involving the law firm Arnold & Porter’s business and clients.
- Arnold & Porter represented Theranos in 2015 when the company demanded the FDA halt inspections of its California sites. The Times said court records show that despite being recused from the matter, Dr. Shuren remained involved.
- In 2019, at the same time Arnold & Porter was working on a $63 billion acquisition of Allergan, Dr. Shuren “initially declined” to recall the company’s breast implants after reports the implants could be tied to a rare cancer.
- In 2014, eye care company Alcon was a client of Ms. Shuren’s while simultaneously working with the FDA on a lens implant.
- Dr. Shuren and Ms. Shuren did not respond to the Times’ interview requests.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
